HenockSaint-JacquesMD

Cardiology • New York, NY

Echocardiography, Nuclear Cardiology, Vascular Medicine

President & Medical Director

Join to view full profile

Dr. Saint-Jacques is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Saint-Jacques' full profile

Already have an account?

Office
1787 Madison Ave
Ste 50C
New York, NY 10035
Phone+1 212-348-9400

Fax+1 212-348-9405
Is this information wrong?

Education & Training

Duke University HospitalPost-Doctoral Fellowship, Research Fellowship- Cardiology, Antiplatelet & Anticoagulant therapy, 2001 - 2003
Duke University HospitalFellowship, Cardiovascular Disease, 2000 - 2003
Montreal Heart InstituteFellowship, Cardiology, 1998 - 2001
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 1995 - 1998
Universidad de Ciencias MedicasClass of 1993

Certifications & Licensure

NY State Medical License 2000 - 2025
NC State Medical License 1999 - 2004
American Board of Internal Medicine Cardiovascular Disease

Awards, Honors, & Recognition

Preceptor Of The Year Touro College of Osteopathic Medicine, New York, NY, 2016
Meaningful Use stage 3 certification Centers for Medicare & Medicaid Services, 2013
Meaningful Use stage 2 certification Center for Medicare & Medicaid Services, 2012
Meaningful Use stage 1 certification Center for Medicare & Medicaid Services, 2011
Resident Of The Year Mount Sinai School of Medicine, CMC Internal Medicine Residency Program, 1995
Summa Cum Laude Probatus, MD Degree University UACA Medical School, San Jose, Costa Rica, 1993
Dean Medal, The Dean list Medical School, UCA University, Costa Rica, 1992
Fellow (FACC) American College of Cardiology
Join now to see all

Clinical Trials

EARLY ACS: Early Glycoprotein IIb/IIIa Inhibition in Patients With Non-ST-segment Elevation Acute Coronary Syndrome (Study P03684AM2)(COMPLETED) Start of enrollment: 2004 Nov 01
Completed
Phase 3
IMPROVE-IT: Examining Outcomes in Subjects With Acute Coronary Syndrome: Vytorin (Ezetimibe/Simvastatin) vs Simvastatin (P04103) Start of enrollment: 2005 Oct 17
Completed
Phase 3
A Study to Compare the Effects of Coreg CR and Coreg IR on Heart Function in Subjects With Stable Chronic Heart Failure Start of enrollment: 2006 Mar 01
Completed
Phase 3
An Efficacy and Safety Study of Rivaroxaban With Warfarin for the Prevention of Stroke and Non-Central Nervous System Systemic Embolism in Patients With Non-Valvular Atrial Fibrillation Start of enrollment: 2006 Dec 01
Completed
Phase 3
An Imaging Study in Patients With Atherosclerosis Taking Rilapladib or Placebo for 12 Weeks Start of enrollment: 2008 Nov 01
Completed
Phase 2
Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events) Start of enrollment: 2011 Apr 11
Completed
Phase 3
A Phase II Study to Assess the Safety, Tolerability and Efficacy of Xanamem™ in Subjects With Mild Dementia Due to AD (XanADu) Start of enrollment: 2017 Mar 23
Completed
Phase 2
Join now to see all

Publications & Presentations

PubMed

6 citations
Diabetes, Heart Failure and Beyond: Elucidating the Cardioprotective Mechanisms of Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors.
Utkarsh Ojha, Lenisse Reyes, Florence Eyenga, Diane Oumbe, Justyna Watkowska, Henock Saint-Jacques> ;American Journal of Cardiovascular Drugs. 2021 Jun 30
1 citations
Exercise-Induced Sustained Ventricular Tachycardia without Structural Heart Disease: A Case Report.
Michelle Audrey Darmadi, Axel Duval, Hanaa Khadraoui, Alberto N Romero, Blanca Simon, Justyna Watkowska, Henock Saint-Jacques> ;The American Journal of Case Reports. 2020 Dec 10
A Late Case of Ischemic Cerebral Event after Resection of a Left Atrial Myxoma.
Reginald Lafleur, Justyna Watkowska, Guoping Zhou, Phenix Alcide, Henock Saint-Jacques> ;Case Reports in Neurology. 2016 May 24
18 citations
Effect of the novel direct factor Xa inhibitor DX-9065a on thrombin generation and inhibition among patients with stable atherosclerotic coronary artery disease
Richard C. Becker, John H. Alexander, Christopher K. Dyke, Yao Huang, Henock Saint-Jacques, Vic Hasselblad, Robert A. Harrington, Edwin G. Bovill> ;Thrombosis Research. 2006 Jan 1
2 citations
Acute coronary syndrome critical pathway: chest PAIN caremap: a qualitative research study--provider-level intervention.
Henock Saint-Jacques, Valentine J Burroughs, Justyna Watkowska, Michelle Valcarcel, Pedro Moreno, Myo Maw> ;Critical Pathways in Cardiology. 2005 Sep 1
13 citations
The PAIN pathway as a tool to bridge the gap between evidence and management of acute coronary syndrome.
Eyal Herzog, Henock Saint-Jacques, Alan Rozanski> ;Critical Pathways in Cardiology. 2004 Mar 1
2 citations
Glycoprotein receptor inhibitors in the management of acute coronary syndromes.
Henock Saint-Jacques, And Robert A Harrington> ;Current Cardiology Reports. 2002 Jul 1
Initial experience with factor-Xa inhibition in percutaneous coronary intervention: the XaNADU-PCI Pilot.
Alexander, J. H., Dyke, C. K., Yang, H., Becker, R. C., Hasselblad, V., Zillman, L. A., Kleiman, N. S., Hochman, J. S., Berger, P. B., Cohen, E. A., Lincoff, A. M., Sa...> ;J Thromb Haemost. 2004 Feb
Join now to see all

Abstracts/Posters

PREDICTORS OF MAJOR HEMORRGAGE FOLLOWING INITIATION OF WARFARIN THERAPY
SAINT-JACQUES, HENOCK, ACC 2004, NEW ORLEANS
Demographic and Predictors of excessive anticoagulation following initiation of warfarin therapy
Saint-Jacques, Henock MD;, American College of Cardiology Annual Scientific Sessions, Chicago, IL, 3/2003